CN110075092A - A kind of respiratory system conditioning essential oil - Google Patents
A kind of respiratory system conditioning essential oil Download PDFInfo
- Publication number
- CN110075092A CN110075092A CN201910507555.8A CN201910507555A CN110075092A CN 110075092 A CN110075092 A CN 110075092A CN 201910507555 A CN201910507555 A CN 201910507555A CN 110075092 A CN110075092 A CN 110075092A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- essential oil
- respiratory system
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a kind of respiratory systems to improve essential oil, including following raw material components: 16 kinds of derived essential oils such as the different menthyl ester of d-limonen, eudesmol, sabinene, o-cymene, menthol, menthones, nopinene, linalool, acetic acid, australene, isomenthone, terpinyl acetate.Its safe without toxic side effect, and have more obvious alleviation and therapeutic effect for the symptoms such as rhinitis, pharyngitis, pneumonia, influenza or disease.
Description
Technical field
The present invention relates to a kind of conditioning essential oil more particularly to a kind of essential oils for improving respiratory system.
Background technique
Essential oil can be combined by 50-500 kinds of different molecules.Under the arrangement of the Nature, these molecules are with perfect
There is so that every kind of plant has its particularity, also therefore act on the profoundness of human body is incomparable broadness to ratio jointly.
Essential oil essence can anti-communicable disease, to antibacterium, virus, mould, can anti-inflammation, anti-spasm promotes cell new old generation
It thanks and cytothesis function, makes life finer.And certain essential oils are adjustable endocrine organ, promote hormone secretion, allow people
The physiology and psychological activity of body, obtain good development.
The effect of plant doctor's essential oil is relatively known from, nothing more than releive and inspire enthusiasm it is this be relatively biased to it is psychological
Effect, but not only in this effect of essential oil.Different types of essential oil is there are also a variety of different effects, for some diseases,
There is the function of releiving and mitigate symptom.Essential oil is all helpful to many diseases, and the treatment with composite medicine can allow disease extensive
It is multiple faster.And the effect of using in daily life, purification air, disinfection, sterilization can be played, while one can be prevented
A little communicable diseases.
Essential oil is for endocrine, metabolism, urinary system, venereal disease, immune system, gynecological disease, muscle, bone disease
Disease, skin disease, the symptom of body and disease, nervous system and mental disease, eye, ear, nose, oral cavity, odontopathy, breathing system
The disease in terms of disease, blood circulation system, the disease in terms of digestive system in terms of uniting have all well and good curative effect.
As the common disease of the infection of the upper respiratory tract and the rhinitis of frequently-occurring disease and pharyngitis, normal protracted course of disease, and can cause
Multiple complications, harm health.Rhinitis is schneiderian membrance or sub-mucosal tissues because of virus infection, germ infection, stimulant stimulation
Deng causing schneiderian membrance or sub-mucosal tissues to be damaged caused acute or chronic inflammation, rhinitis causes to generate excessive mucus, usually
Cause the symptoms such as runny nose, nasal obstruction；Pharyngitis is the inflammation of pharyngeal mucosa, submucous tissue, is often a part of the infection of the upper respiratory tract,
According to the length of the course of disease and the difference of pathological change property, it is divided into acpuei pharyngitis, chronic pharyngitis two major classes.Although currently on the market
There is the drug for largely treating such symptom, but still is difficult to eradicate.
Based on this, a kind of essence that can be effectively relieved and treat the symptoms such as rhinitis, pharyngitis, pneumonia, influenza or disease is provided
Oil is particularly important.
Summary of the invention
For the defects in the prior art, the present invention is intended to provide a kind of respiratory system conditioning essential oil and preparation method thereof with
Using.Essential oil provided by the invention selects the plant extract containing active skull cap components to form, and prescription proportion science is not added and appointed
Who work synthesizes component, safe without toxic side effect, and there is excellent clear haze dredging collateral, antiallergic promoting the dispersing function of the lung, logical nose to stop tears, smooth throat to stop cough
And the effect of enhancing human immunity, it can be effectively relieved and cure the symptoms such as rhinitis, pharyngitis, pneumonia, influenza or disease.This
Outside, essential oil provided by the invention is significant in efficacy, stability is good, easy to use, is with a wide range of applications.
It may be noted that the present invention is improvement on the basis of the applicant is in patent applied for CN201710249758.2.
Specifically, we have further refined the parts by weight of each component on the basis of the technical solution of above-mentioned patent application, and increase
Several derived essential oils are added, so that proportion is more balanced, effect is more excellent.
For this purpose, the invention provides the following technical scheme:
A kind of respiratory system conditioning essential oil, raw material components are by weight, comprising: d-limonen 20-25 parts by weight, eucalyptus
Leaf oil alcohol 15-25 parts by weight, australene 5-15 parts by weight, menthol 5-15 parts by weight, menthones 5-10 parts by weight, nopinene 2-
5 parts by weight, terpinyl acetate 2-5 parts by weight, isomenthone 2-4 parts by weight, linalool 2-5 parts by weight, sabinene 1-3 parts by weight,
The different menthyl ester 1-3 parts by weight of o-cymene 1-3 parts by weight, acetic acid, β-carypohyllene 0.1-2 parts by weight, borneolacetate 0.1-2 weight
Measure part, terpineol 0.1-2 parts by weight, β-heerabolene 0.01-1 parts by weight.
Further, a kind of respiratory system improves essential oil, and raw material components are by weight, comprising: d-limonen 22-23
Parts by weight, eudesmol 21-22 parts by weight, australene 10-11 parts by weight, menthol 8-9 parts by weight, menthones 6-7 parts by weight,
Nopinene 3-4 parts by weight, terpinyl acetate 2-3 parts by weight, isomenthone 2-3 parts by weight, linalool 2-3 parts by weight, sabinene 1-2
Parts by weight, o-cymene 1-2 parts by weight, the different menthyl ester 1-2 parts by weight of acetic acid, β-carypohyllene 0.5-1 parts by weight, borneolacetate
0.2-0.6 parts by weight, terpineol 0.5-1 parts by weight, β-heerabolene 0.01-0.2 parts by weight.
Further, a kind of respiratory system improves essential oil, and raw material components are by weight, comprising: d-limonen 22.93
Parts by weight, 21.71 parts by weight of eudesmol, 10.76 parts by weight of australene, 8.79 parts by weight of menthol, 6.49 weight of menthones
Part, 3.26 parts by weight of nopinene, 2.88 parts by weight of terpinyl acetate, 2.85 parts by weight of isomenthone, 2.80 parts by weight of linalool,
Different 1.69 parts by weight of menthyl ester of 1.80 parts by weight of sabinene, 1.65 parts by weight of o-cymene, acetic acid, 0.70 parts by weight of β-carypohyllene,
0.50 parts by weight of borneolacetate, 0.94 parts by weight of terpineol, 0.06 parts by weight of β-heerabolene.
Further, each ingredient lists and its retention time and content are as follows:
Above-mentioned essential oil can be selected from commercial product, can also pass through supercritical carbon dioxide extracting or vapor from plant
The way of distillation, which is extracted, to be obtained.
On the other hand, since component is pure essential oil, the preparation method of essential oil of the present invention is directly by above 16 kinds
Essential oil be uniformly mixed to get.
The preparation method of essential oil of the present invention can also be using preparation method disclosed in CN201710249758.2, further
β-carypohyllene, borneolacetate, terpineol, β-heerabolene is added.
On the other hand, essential oil is applied to throat by the application method of essential oil provided by the invention, and massage absorbs.It is right
In patients with rhinitis, essential oil can also be dripped in nasal cavity.
In addition to advantage described in above-mentioned patent, essential oil of the invention is due to belonging to pure essential oil formulation, safe and non-toxic secondary work
With, and have more obvious alleviation and therapeutic effect for the symptoms such as rhinitis, pharyngitis, pneumonia, influenza or disease.
Specific embodiment
Embodiment 1
A kind of respiratory system conditioning essential oil, is made: 22.93 parts by weight of d-limonen, eucalyptus oil of following raw material components
21.71 parts by weight of alcohol, 10.76 parts by weight of australene, 8.79 parts by weight of menthol, 6.49 parts by weight of menthones, nopinene 3.26
Parts by weight, 2.88 parts by weight of terpinyl acetate, 2.85 parts by weight of isomenthone, 2.80 parts by weight of linalool, 1.80 weight of sabinene
Part, 1.65 parts by weight of o-cymene, different 1.69 parts by weight of menthyl ester of acetic acid, 0.70 parts by weight of β-carypohyllene, borneolacetate
0.50 parts by weight, 0.94 parts by weight of terpineol, 0.06 parts by weight of β-heerabolene.Above-mentioned each raw material component is uniformly mixed, is obtained
Essential oil.
Embodiment 2
A kind of respiratory system conditioning essential oil, is made: 23 parts by weight of d-limonen, eudesmol 22 of following raw material components
Parts by weight, 11 parts by weight of australene, 9 parts by weight of menthol, 7 parts by weight of menthones, 4 parts by weight of nopinene, 3 weight of terpinyl acetate
Measure part, 3 parts by weight of isomenthone, 3 parts by weight of linalool, 2 parts by weight of sabinene, 2 parts by weight of o-cymene, the different menthyl ester 2 of acetic acid
Parts by weight, 1 parts by weight of β-carypohyllene, 1 parts by weight of borneolacetate, 1 parts by weight of terpineol, 0.1 parts by weight of β-heerabolene.It will be upper
It states each raw material component to be uniformly mixed, obtains essential oil.
Embodiment 3
A kind of respiratory system conditioning essential oil, is made: 24 parts by weight of d-limonen, eudesmol 21 of following raw material components
Parts by weight, 12 parts by weight of australene, 10 parts by weight of menthol, 8 parts by weight of menthones, 5 parts by weight of nopinene, terpinyl acetate 2
Parts by weight, 2 parts by weight of isomenthone, 4 parts by weight of linalool, 3 parts by weight of sabinene, 1 parts by weight of o-cymene, the different menthyl ester of acetic acid
3 parts by weight, 3 parts by weight of β-carypohyllene, 1 parts by weight of borneolacetate, 1 parts by weight of terpineol, 0.2 parts by weight of β-heerabolene.It will
Above-mentioned each raw material component is uniformly mixed, and obtains essential oil.
Embodiment 4
A kind of respiratory system conditioning essential oil, is made: 21 parts by weight of d-limonen, eudesmol 23 of following raw material components
Parts by weight, 13 parts by weight of australene, 9 parts by weight of menthol, 7 parts by weight of menthones, 6 parts by weight of nopinene, 3 weight of terpinyl acetate
Measure part, 4 parts by weight of isomenthone, 5 parts by weight of linalool, 4 parts by weight of sabinene, 2 parts by weight of o-cymene, the different menthyl ester 2 of acetic acid
Parts by weight, 1 parts by weight of β-carypohyllene, 3 parts by weight of borneolacetate, 2 parts by weight of terpineol, 0.2 parts by weight of β-heerabolene.It will be upper
It states each raw material component to be uniformly mixed, obtains essential oil.
Embodiment 5
A kind of respiratory system conditioning essential oil, is made: 23 parts by weight of d-limonen, eudesmol 21 of following raw material components
Parts by weight, 13 parts by weight of australene, 8 parts by weight of menthol, 6 parts by weight of menthones, 5 parts by weight of nopinene, 4 weight of terpinyl acetate
Measure part, 5 parts by weight of isomenthone, 6 parts by weight of linalool, 3 parts by weight of sabinene, 1 parts by weight of o-cymene, the different menthyl ester 2 of acetic acid
Parts by weight, 3 parts by weight of β-carypohyllene, 1 parts by weight of borneolacetate, 3 parts by weight of terpineol, 0.3 parts by weight of β-heerabolene.It will be upper
It states each raw material component to be uniformly mixed, obtains essential oil.
Embodiment 6
Staphylococcus aureus pharynx nasalis bacterial bearing rate be 20%-50%, the bacterial bearing rate of medical worker may be up to 70% with
On, it is the important source of infection for curing cross infection in hospital.Essential oil prepared by the embodiment of the present invention 1 is transferred to Ying Geer certification inspection by us
Survey group (ICAS) Ying Geer detection technique services (Shanghai) Co., Ltd. and is detected, and obtains on 01 11st, 2019
Examining report, report number SHC19010034-01.As a result as follows:
Detection method: GB15979-2002 Disposable Sanitary Accessory sanitary standard appendix C 3
Test strain and number: staphylococcus aureus ATCC 6538
Strain concentration: staphylococcus aureus 6.0 × 105CFU/mL
Activity: stoste
Test result:
Judgment basis: sterilizing rate >=90%, product have bactericidal effect.
Antibacterial effect evaluation: product has staphylococcus aureus in action time 2min, 5min, 10min, 20min
Bactericidal effect.
Embodiment 7
Pseudomonas aeruginosa is commonly called as Pseudomonas aeruginosa, the wet environment being distributed widely in nature and hospital, immunity
Low person and inpatient recall rate are high, are conditioned pathogen, are one of the main pathogenic fungis of nosocomial infection, account for hospital-acquired infection
10% or so.Essential oil prepared by the embodiment of the present invention 1 is transferred to Ying Geer authentication checks group (ICAS) Ying Geer to examine by we
Survey technology services (Shanghai) Co., Ltd. and is detected, and obtains examining report on 01 28th, 2019, and report number is
SHC19010388-01A.As a result as follows:
Detection method: GB15979-2002 Disposable Sanitary Accessory sanitary standard appendix C 3
Test strain and number: pseudomonas aeruginosa ATCC 9027
Strain concentration: pseudomonas aeruginosa 8.0 × 105CFU/mL
Activity: stoste
Test result:
Judgment basis: sterilizing rate >=90%, product have bactericidal effect.
Antibacterial effect evaluation: product kills pseudomonas aeruginosa in action time 2min, 5min, 10min, 20min
Bacterium effect.
Embodiment 8
H1N1 is a kind of virus that orthomyxoviridae family's influenza A virus belongs to, in mid-March, 2009 Mexico and U.S.'s phase
After the Influenza epidemic situation as caused by a kind of new influenza virus has occurred, start to be named as " people infects swine flu ", then research hair
Now the virus is a kind of mixture, it has concentrated the characteristic of swine influenza virus, human influenza virus and avian influenza virus.April 30
WHO is changed to " A type HINl influenza ".Essential oil prepared by the embodiment of the present invention 1 is transferred to Ying Geer authentication checks group by us
(ICAS) Ying Geer detection technique services (Shanghai) Co., Ltd. and is detected, and detection report was obtained on 03 15th, 2019
It accuses, report number SHC19010388-01C.As a result as follows:
Test method: referring to " disinfection technology standard " version -2.1.1.10.7 in 2002
Activity: stoste
Action time: 10min
Test result:
Remarks: negative control group test result meets full terms as defined in evaluation
As it can be seen that compared with negative control group, test group has apparent killing effect for H1N1 virus.
Embodiment 9
Streptococcus pneumonia is generally called pneumococcus, this bacterium is distributed widely in nature, is often lodged in the nasopharyngeal cavity of normal person
In.Most not pathogenic or pathogenicities are weak, and only minority has pathogenicity.Pneumococcal pneumonia is by the microbial lung of pneumonia streptococcus
Inflammation occupies community acquired pneumonia first place, accounts for about half.Essential oil prepared by the embodiment of the present invention 1 is transferred to Ying Geer to authenticate by we
Detection group (ICAS) Ying Geer detection technique services (Shanghai) Co., Ltd. and is detected, and obtains on 03 15th, 2019
Examining report, report number SHC19010388-01B.As a result as follows:
Test method: referring to " disinfection technology standard " (version in 2002) second part -2.1.1.7
Activity: stoste
Action time: 10min
Test result:
As it can be seen that product has bactericidal effect for streptococcus pneumonia.
To sum up, the increase of β-carypohyllene, borneolacetate, terpineol, β-heerabolene ingredient, the sterilization for enhancing essential oil disappear
Scorching ability, test proves that staphylococcus aureus, pseudomonas aeruginosa, streptococcus pneumonia, H1N1 disease can be killed effectively
Poison, while the immunity of human body can be promoted.
Claims (6)
1. a kind of respiratory system improves essential oil, raw material components are by weight, comprising: d-limonen 20-25 parts by weight, folium eucalypti
Oleyl alcohol 15-25 parts by weight, australene 5-15 parts by weight, menthol 5-15 parts by weight, menthones 5-10 parts by weight, nopinene 2-5
Parts by weight, terpinyl acetate 2-5 parts by weight, isomenthone 2-4 parts by weight, linalool 2-5 parts by weight, sabinene 1-3 parts by weight, neighbour
The different menthyl ester 1-3 parts by weight of cymene 1-3 parts by weight, acetic acid, β-carypohyllene 0.1-2 parts by weight, borneolacetate 0.1-2 weight
Part, terpineol 0.1-2 parts by weight, β-heerabolene 0.01-1 parts by weight.
2. a kind of respiratory system as described in claim 1 improves essential oil, raw material components are by weight, comprising: dextrorotation lemon
Alkene 22-23 parts by weight, eudesmol 21-22 parts by weight, australene 10-11 parts by weight, menthol 8-9 parts by weight, menthones 6-7
Parts by weight, nopinene 3-4 parts by weight, terpinyl acetate 2-3 parts by weight, isomenthone 2-3 parts by weight, linalool 2-3 parts by weight,
Sabinene 1-2 parts by weight, o-cymene 1-2 parts by weight, the different menthyl ester 1-2 parts by weight of acetic acid, β-carypohyllene 0.5-1 parts by weight, second
Sour norbornene ester 0.2-0.6 parts by weight, terpineol 0.5-1 parts by weight, β-heerabolene 0.01-0.2 parts by weight.
3. a kind of respiratory system as described in claim 1 improves essential oil, raw material components are by weight, comprising: dextrorotation lemon
22.93 parts by weight of alkene, 21.71 parts by weight of eudesmol, 10.76 parts by weight of australene, 8.79 parts by weight of menthol, menthones
6.49 parts by weight, 3.26 parts by weight of nopinene, 2.88 parts by weight of terpinyl acetate, 2.85 parts by weight of isomenthone, linalool
Different 1.69 parts by weight of menthyl ester of 2.80 parts by weight, 1.80 parts by weight of sabinene, 1.65 parts by weight of o-cymene, acetic acid, β-carypohyllene
0.70 parts by weight, 0.50 parts by weight of borneolacetate, 0.94 parts by weight of terpineol, 0.06 parts by weight of β-heerabolene.
4. a kind of respiratory system as described in claim 1 improves essential oil, the essential oil can be selected from commercial product, can also be from
It is obtained in plant by supercritical carbon dioxide extracting or extraction by steam distillation.
5. a kind of preparation method of respiratory system conditioning essential oil as described in claim 1, directly mixes above 16 kinds of essential oils
Uniformly to get.
6. a kind of application method of respiratory system conditioning essential oil as described in claim 1, is applied to throat for essential oil, presses
Rub absorption.For patients with rhinitis, essential oil can also be dripped in nasal cavity.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910507555.8A CN110075092A (en) | 2019-06-12 | 2019-06-12 | A kind of respiratory system conditioning essential oil |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910507555.8A CN110075092A (en) | 2019-06-12 | 2019-06-12 | A kind of respiratory system conditioning essential oil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110075092A true CN110075092A (en) | 2019-08-02 |
Family
ID=67424182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910507555.8A Withdrawn CN110075092A (en) | 2019-06-12 | 2019-06-12 | A kind of respiratory system conditioning essential oil |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110075092A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114601866A (en) * | 2020-12-08 | 2022-06-10 | 北京远大九和药业有限公司 | Composition for treating or preventing viral influenza and application thereof |
| CN115484922A (en) * | 2020-05-01 | 2022-12-16 | 宝洁公司 | Mint flavor composition |
-
2019
- 2019-06-12 CN CN201910507555.8A patent/CN110075092A/en not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115484922A (en) * | 2020-05-01 | 2022-12-16 | 宝洁公司 | Mint flavor composition |
| CN114601866A (en) * | 2020-12-08 | 2022-06-10 | 北京远大九和药业有限公司 | Composition for treating or preventing viral influenza and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stea et al. | Essential oils for complementary treatment of surgical patients: state of the art | |
| Buckle | The role of aromatherapy in nursing care | |
| CN105833279B (en) | External-use medicine composition for treating various wound surfaces of skin and preparation method thereof | |
| TW201408200A (en) | Mite killing bactericide and preparation method of mite killing bactericide | |
| CN102512490A (en) | Aromatherapy essential oil for treating gynecological inflammation and essential oil aromatherapy patch | |
| CN110075092A (en) | A kind of respiratory system conditioning essential oil | |
| DE19953829A1 (en) | New nasal spray containing vitamin C and extracts of Bulpeurum Scorzonerifolium Willd, Radix lastidis Indigotica and Folium lastidis for treating colds, fever and influenza | |
| CN105148059A (en) | Plant oil external liniment capable of repelling mosquitos and preparation method thereof | |
| CN103169754B (en) | Traditional Chinese medicinal composition for treating asthma | |
| CN105687021A (en) | Foot powder for preventing tinea pedis | |
| CN106309746A (en) | Traditional Chinese medicine composition, preparation method thereof and oral health product | |
| CN106237029B (en) | A kind of aloe antibiotic gel and preparation method thereof | |
| CN111481567B (en) | Compound ozone oil and preparation method and application thereof | |
| CN110652581A (en) | Medical ray protection solution with moisturizing and itching relieving effects and preparation method thereof | |
| CN113785847A (en) | A fumigant with effects of eliminating dampness, removing toxic substance and avoiding plague, and its preparation method | |
| Basappa et al. | Natural alternatives to antibiotic agents | |
| Jain et al. | Utilization of menthe, camphor, eucalyptus and other volatile oils in quick remedies for nasal congestion | |
| CN111012823A (en) | Medicine containing lindera glauca volatile oil and administration method thereof | |
| CN108635362A (en) | A kind of pharmaceutical composition for treating diabetes | |
| CN108524622A (en) | A kind of tapon for killing vagina mould | |
| CN1085946C (en) | External medicine with anti-infections and recovery function | |
| CN114533797B (en) | Throat-clearing composition, throat-clearing antibacterial liquid, preparation method and application | |
| CN102068506A (en) | Sterilizing and antimicrobial Chinese medicinal disinfectant | |
| CN109589381A (en) | A kind of Chinese medicinal formulae of preventing phlegm from forming and stopping coughing | |
| Brightman | Tetanus: an ever‐present infection risk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190802 |
|
| WW01 | Invention patent application withdrawn after publication |